$XBI $115.17 -2.6%%
Covid Updates
$MRNA -1.2% Moderna Announces Switzerland Exercises its Option to Purchase Seven Million Additional Doses of Moderna's COVID-19 Booster Vaccine in 2022. source
$SRNE -2.8% Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant. source
$SRNE -2.8% Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market. source
Pipeline Updates
$MBRX -8.4% Moleculin Announces Preliminary Third Cohort Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases. source
$IMAB -1.3% I-Mab Announces IND Approval from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors. source
$TCON -20.2% TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Review of Interim Safety and Efficacy Data from the Ongoing ENVASARC Pivotal Trial. source
$BCLI -0.3% FDA Authorizes Further NurOwn® Dosing Under Expanded Access Program. source
$BBIO -72.0% BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study. source
$STRO +2.3% Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer. source
$STRO +2.3% Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China. source
Business Updates
$
Posted by FS/JM
Comments